Scientists at Israel’s Technion Institute have found that misfolding proteins in the brain cells of ALS and Huntington’s sufferers can be corrected by other proteins already in the cell, called “chaperones”. But the cell doesn’t activate them or activates the … Continue reading →

Although not an Israeli treatment, Israel’s Sheba Medical Center is one of the few global hospitals treating prostate cancer patients with Lutetium-177 therapy. It attaches to prostate-specific membrane antigens (PSMAs) on tumors and emits beta radiation to neutralize them. https://www.shebaonline.org/how-does-lutetium-177-therapy-work/

Israel’s New Phase has developed hyperthermic treatment that kills up to 50% of metastatic cancer. In animal and human trials, iron-oxide nanoparticles, produced in a lab managed by three Druze Arab women, are injected into stage 4 cancer patients, and … Continue reading →